Medtronic's 2025 Gains and Diabetes Spin-Off

Cramer introduces Jeff Marthin to discuss Medtronic's momentum, diabetes spin-off, and new FDA approvals.

Play episode from 18:31

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!